Cancer Immunotherapy Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportuni

The cancer immunotherapy market is estimated to grow from USD 134.95 billion in 2022 to USD 273.32 billion by 2028 at a CAGR of 12.33% during the forecast period. Cancer immunotherapy is a revolutionary approach to cancer treatment that uses the body's immune system to combat cancer cells. Unlike traditional cancer treatments such as chemotherapy and radiation therapy, which directly target cancer cells, immunotherapy works by enhancing the body's natural defenses, allowing cancer cells to be recognized and attacked more effectively.